Recent Articles

• 
  Biotech

  "Gene-Editing Tech for Climate Crisis Solutions"

  Professor Jin-Soo Kim from KAIST, who founded 'ToolGen', 'GreenGene', and 'EdGene', is a world-renowned authority in the field of gene editing. After leaving Korea in 2022 to serve as a visiting professor at the National University of Singapore, he returned to KAIST earlier this year under the 'post

  2025.10.20
• 
  Medical / Clinical Case

  "Multidisciplinary Approach Seeks Best Lymphoma Treatments"

  Multidisciplinary consultation at the Lymphoma Center of the Hematology Hospital at Seoul St. Mary's Hospital. Medical staff propose and decide on treatment methods in the presence of the patient (left). As of September this year, the Lymphoma Center has conducted over 4,160 multidisciplinary consul

  2025.10.18
• 
  MedTech

  Padotada Launches Customer-Centric Supplements Initiative

  [Seoul City University has been leading youth entrepreneurship and regional innovation since 2022, under the vision of 'The Most Seoul-like Influence, The Most Global Value' with the 'Seoul Impact' project. The university particularly supports startups in AI-based urban innovation and social impact

  2025.10.17
• 
  Samsung Biologics

  Samsung Biologics' Spin-off Approved, Boosts CDMO Competitiveness

  Samsung Biologics has formalized its independent structure as a 'pure CDMO (Contract Development and Manufacturing Organization) company.' On the 17th, the company presented a proposal for a spin-off at an extraordinary general meeting of shareholders held at Songdo Convensia in Incheon, which passe

  2025.10.17
• 
  Biotech

  Choi Lab: Biogas Tech Pioneers Energy Future

  ※ The Seoul National University of Science and Technology's Startup Support Group assists promising startups with space, mentoring, networking, and commercialization support through its Business Incubation Center, aiding their growth. 'Startup in Science and Technology University' shares stories of

  2025.10.17
• 
  Medical / Bio Business

  Samsung Bio's CDMO, New Drug Units to Split

  Samsung Biologics Announces Spin-off Samsung Biologics will complete the spin-off of its Contract Development and Manufacturing Organization (CDMO) business and biosimilar business on November 1. Trading of Samsung Biologics' shares will be suspended from October 30 to November 21, and the newly est

  2025.10.17
• 
  Medical / Clinical Case

  Inha Hospital: Radiation Targets Inoperable Lung Tumors

  Professor Kim Heon-jeong of the Department of Radiation Oncology at Inha University Hospital explains the process and effects of radiotherapy surgery for lung cancer patients. Provided by Inha University Hospital In December 2023, Park Young-cheol (alias, 79) visited Inha University Hospital after a

  2025.10.17
• 
  Healthcare / Beauty Science

  LG Study: Facial Aging Varies by Area

  LG Household & Health Care announced on the 16th that it has successfully identified differences in the aging speed of various facial areas, such as the eye area, lips, and facial contours, using 'Vision Artificial Intelligence (AI)' technology. This study was published in the online edition of the

  2025.10.17
• 
  Medical / Digital Healthcare

  Startup-ing: Ecen Aids Post-Discharge Recovery

  Surgery completion does not signify the end of treatment. Continuous monitoring is crucial even after patients return home. However, self-rehabilitation is not easy for patients with mobility issues, and revisiting the hospital for simple progress checks can be burdensome. Medical staff also face li

  2025.10.16
• 
  Medical / Drug Development

  Daewon Pharmaceutical Advances DW4421 to Phase 3 Trials

  Daewon Pharmaceutical announced on the 16th that the clinical phase 3 trial plan (IND, Investigational New Drug: approval procedure for new drug clinical trials) for its next-generation P-CAB (Potassium-Competitive Acid Blocker, a drug group that inhibits gastric acid production by competitively act

  2025.10.16